EUVIMEDEUVIMED entdecken
Crossref

Upregulated PCAT-1 predicts poor prognosis and reduced immune cell infiltration in head and neck squamous cell carcinoma through the miR-145-5p / FSCN-1 axis

Maryam Pirhoushiaran, Roozbeh Heidarzadehpilehrood, Mahnoosh Mokhtarinejad, Sara Hesami, Nima Rezaei, Abbas Shakoori Farahani

Molecular Biology Reports · 2025

DOI: 10.1007/s11033-024-10208-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2025. Verfasst von Maryam Pirhoushiaran und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, 1417613151, Iran. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, Microfilament Proteins, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Tehran University of Medical Sciences (TUMS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: LncRNA PCAT-1 is known to promote cancer proliferation, invasion, and metastasis. However, its significance in HNSCC is not fully understood. This research investigates how the PCAT-1 / miR-145-5p / FSCN-1 axis promote HNSCC. METHODS AND RESULTS: We analyzed the gene expression patterns on 238 fresh-frozen samples, comparing tumors with their normal adjacent tissues (NATs). HNSCC samples showed higher PCAT-1 and FSCN-1 expression compared to NATs (p < 0.001 and p < 0.001, respectively). In contrast, miR-145-5p expression was markedly downregulated compared to NATs (p < 0.001). Notably, ROC curve analysis revealed exceptional diagnostic power, with an AUC of 0.83 for PCAT-1, 0.95 for miR-145-5p, and 0.91 for FSCN-1. Pearson correlation analysis unveiled a significant positive correlation between PCAT-1 and FSCN-1 expression levels (r = 0.084, p < 0.001) and negative correlations between FSCN-1 and miR-145-5p (r = -0.710, p < 0.001) as well as between PCAT-1 and miR-145-5p (r = -0.759, p < 0.001). Distinct molecular profiles were observed in the levels of PCAT-1, miR-145-5p, and FSCN-1 between HPV (-) and HPV ( +) 16 and 18 genotypes (p = 0.007, p = 0.027, and p = 0.002). MiR-145-5p expression showed significant differences between HPV (-) and HPV ( +) other genotypes (p = 0.035). FSCN-1 expression showed notable distinctions between HPV ( +) 18 & 16 and HPV ( +) other genotypes (p = 0.031). CONCLUSIONS: Elevated levels of lncRNA PCAT-1 promote HNSCC through the miR-145-5p/FSCN-1 axis and are associated with poor prognosis and reduced immune cell infiltration levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsRNA, Long NoncodingMicrofilament ProteinsSquamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsCarrier ProteinsHumansPrognosisMaleFemaleMiddle AgedGene Expression Regulation, NeoplasticUp-RegulationAgedBiomarkers, Tumor

Stichwörter der Autor:innen

FSCN-1miRNA-145-5pHPV genotypeHead and neck squamous cell carcinomaPCAT-1SmokingTumor infiltration

Substanzen

MicroRNAsMIRN145 microRNA, humanRNA, Long NoncodingFSCN1 protein, humanMicrofilament ProteinsCarrier Proteinslong non-coding RNA PCAT1, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, 1417613151, Iran.
  • Department of Obstetrics & Gynaecology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia.
  • Medical Genetic Ward, Faculty of Medicine, Imam Khomeini Hospital Complex, IKHC, Tehran University of Medical Sciences, Tehran, Iran.
  • Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Stockholm, Sweden.

Förderung

  • Tehran University of Medical Sciences (TUMS)

Zitieren

APA

Pirhoushiaran, M., Heidarzadehpilehrood, R., Mokhtarinejad, M., Hesami, S., Rezaei, N., & Farahani, A. S. (2025). Upregulated PCAT-1 predicts poor prognosis and reduced immune cell infiltration in head and neck squamous cell carcinoma through the miR-145-5p / FSCN-1 axis. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-10208-1

Vancouver

Pirhoushiaran M, Heidarzadehpilehrood R, Mokhtarinejad M, Hesami S, Rezaei N, Farahani AS. Upregulated PCAT-1 predicts poor prognosis and reduced immune cell infiltration in head and neck squamous cell carcinoma through the miR-145-5p / FSCN-1 axis. Molecular Biology Reports. 2025. doi:10.1007/s11033-024-10208-1

BibTeX
@article{Pirhoushiaran2025,
  author = {Pirhoushiaran, Maryam and Heidarzadehpilehrood, Roozbeh and Mokhtarinejad, Mahnoosh and Hesami, Sara and Rezaei, Nima and Farahani, Abbas Shakoori},
  title = {Upregulated PCAT-1 predicts poor prognosis and reduced immune cell infiltration in head and neck squamous cell carcinoma through the miR-145-5p / FSCN-1 axis},
  journal = {Molecular Biology Reports},
  year = {2025},
  doi = {10.1007/s11033-024-10208-1}
}
Kostenlos starten →